EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer

Jun-Yi Xu iD, Mao-Qi Tian, Rui Yang, Zi-Xuan Li iD, Zi-Heng Lin, Yu-Fei Wang, Yu-Hang Chu, Wei-Ning Sun iD, Ya-Mei Wang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27020713 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jun-Yi Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing 100069, China. Hauptthemen laut MEDLINE: Cisplatin, Ovarian Neoplasms, Drug Resistance, Neoplasm, Cadherins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific Research Program of Beijing Municipal Commission of Education, the Scientific Research and Innovation Program of Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC), the third most common gynecologic malignancy, is characterized by high mortality largely driven by chemotherapy resistance, leading to recurrence and metastasis. Using transcriptomic data from GSE73935, we constructed a weighted gene co-expression network and identified eight hub genes (IGF1R, CDH2, PDGFRA, CDKN1A, SHC1, SPP1, CAV1 and FGF18) associated with cisplatin resistance, among which CDH2 emerged as the most clinically relevant candidate. CDH2 demonstrated moderate diagnostic potential (AUC = 0.792) and was markedly upregulated in cisplatin-resistant A2780/CP70 cells. Independent validation using clinical single-cell RNA-seq data (GSE211956) confirmed its selective enrichment in resistant tumor cell subpopulations. Gene set enrichment analysis linked elevated CDH2 expression to p53 signaling, DNA replication, nucleotide excision repair, and Toll-like receptor pathways, with qPCR supporting upregulation of key downstream genes in resistant cells. Immune deconvolution further indicated that high CDH2 expression correlated with increased infiltration of NK cells, Tregs, macrophages, and neutrophils, and immunohistochemistry verified CDH2 overexpression in cisplatin-resistant tissues. In addition, virtual screening and drug sensitivity profiling identified several FDA-approved agents with potential relevance to CDH2-associated drug response. These findings indicate that CDH2 may serve as a candidate marker associated with cisplatin response in OC, and its association with immune cell infiltration provides further insight into mechanisms potentially underlying chemoresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinOvarian NeoplasmsDrug Resistance, NeoplasmCadherinsFemaleHumansGene Expression Regulation, NeoplasticPrognosisAntineoplastic AgentsGene Regulatory NetworksCell Line, TumorGene Expression ProfilingBiomarkers, Tumor

Stichwörter der Autor:innen

cadherin 2 (CDH2)cisplatin resistancedrug screeninggene set enrichment analysisimmune infiltrationovarian cancer

Substanzen

CisplatinCadherinsAntineoplastic AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing 100069, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing 100069, China.

ORCID-Profile: Jun-Yi Xu, Zi-Xuan Li, Wei-Ning Sun, Ya-Mei Wang

Förderung

  • The Scientific Research Program of Beijing Municipal Commission of Education
  • the Scientific Research and Innovation Program of Capital Medical University

Zitieren

APA

Xu, J. Y., Tian, M. Q., Yang, R., Li, Z. X., Lin, Z. H., Wang, Y. F., Chu, Y. H., Sun, W. N., & Wang, Y. M. (2026). Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020713

Vancouver

Xu JY, Tian MQ, Yang R, Li ZX, Lin ZH, Wang YF, et al. Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020713

BibTeX
@article{Xu2026,
  author = {Xu, Jun-Yi and Tian, Mao-Qi and Yang, Rui and Li, Zi-Xuan and Lin, Zi-Heng and Wang, Yu-Fei and Chu, Yu-Hang and Sun, Wei-Ning and Wang, Ya-Mei},
  title = {Integrated Analyses Identify CDH2 as a Hub Gene Associated with Cisplatin Resistance and Prognosis in Ovarian Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27020713}
}
Kostenlos starten →